| dronabinol oral / Generic mfg. |
| Ongoing | 3 | 492 | Europe | Dronabinol, | Plymouth Hospitals NHS Trust | Progressive multiple sclerosis | | | | |
| Recruiting | 2a | 20 | RoW | SCI -110, Dronabinol and PEA | The Israeli Medical Center for Alzheimer's | Alzheimer Disease | 06/23 | 06/23 | | |
2017-004823-66: Early-life stress, the endocannabinoid system, and fear memory extinction |
|
|
| Ongoing | 2 | 48 | Europe | Namisol, Hydrocortison CF, ECP002A, RVG 50730, Tablet, Hydrocortison CF | Radboudumc, Radboudumc | healthy volunteers gezonde vrijwilligers, intended indication: posttraumatic stress disorder (PTSD) beoogde indicatie: posttraumatic stress disorder (PTSD), Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
2018-000014-38: A Phase IIa Study to Determine the Safety, Tolerability and Efficacy of a daily oral dose of THX-110 in Adult Patients with Tourette Syndrome (TS) |
|
|
| Not yet recruiting | 2 | 60 | Europe | THX-110 [Dronabinol], THX-110 [PEA (Palmitoylethanolamide)], Capsule, soft, Tablet, Dronabinol Capsules, USP | Therapix Biosciences Ltd., Therapix Biosciences Ltd. | Tourette Syndrome, Neuropsychiatric disorder characterized by multiple motor or vocal tics., Diseases [C] - Nervous System Diseases [C10] | | | | |
| Completed | 2 | 75 | US | Dronabinol (Marinol®), Placebo | Johns Hopkins University, Mclean Hospital, Miami Jewish Health, National Institute on Aging (NIA), Tufts Medical Center | Alzheimer's Disease | 05/24 | 05/24 | | |
NCT05612711: Dronabinol for Agitation in Dementia Crossover Trial |
|
|
| Not yet recruiting | 2 | 50 | US | Dronabinol, Marinol | Ralph H. Johnson VA Medical Center, JHSPH Center for Clinical Trials | Dementia Moderate, Dementia Severe, Agitation,Psychomotor, Behavioral Symptoms | 11/25 | 11/26 | | |
NCT05269628: Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype |
|
|
| Recruiting | 2 | 166 | US | Cannabidiol (CBD), Epidiolex®, Tetrahydrocannabinol (THC), Marinol®, dronabinol, Placebo CBD, Placebo THC | Tiffany J. Braley, MD, MS, National Center for Complementary and Integrative Health (NCCIH) | Multiple Sclerosis, Sleep, Pain | 06/26 | 06/26 | | |
NCT02492074: Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study |
|
|
| Not yet recruiting | 1 | 60 | Europe | Delta-9-tetrahydrocannabinol, Dronabinol, Cannabidiol, Placebo | Central Institute of Mental Health, Mannheim | Healthy Volunteers, Modeling Psychosis | 04/25 | 05/25 | | |
NCT04231643: Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers |
|
|
| Terminated | 1 | 19 | US | Dronabinol, Epidiolex, Placebos | University of California, San Diego, National Institute on Drug Abuse (NIDA) | Bipolar Disorder | 11/23 | 11/23 | | |
NCT04080427: Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study |
|
|
| Recruiting | 1 | 100 | US | Placebo capsule, sugar pill, Dronabinol 7.5 milligram oral capsule, Marinol | Wayne State University, National Institute of Mental Health (NIMH) | Posttraumatic Stress Disorder | 12/24 | 12/25 | | |
| Recruiting | N/A | 180 | Europe | Dronabinol 2.5 mg, Placebo | Charite University, Berlin, Germany | Post Traumatic Stress Disorder | 03/24 | 03/24 | | |
